References
- Sartorius N. Physical symptoms of depression as a public health concern. J Clin Psychiatry 2003; 64(Suppl 7)3–4
- Depression Guideline Panel. Clinical practice guideline number 5: Depression in primary care, Volume 1: Detection and diagnosis. Rockville, MD: US Dept of Health & Human Services, Public Health Service, Agency for Health Care Policy & Research; 1993. AHCR publication 93-0550.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
- Trivedi MH, Rush AJ, Crismon ML, et al. Clinical results for patients with major depressive disorder in the Texas medication algorithm project. Arch Gen Psychiatry 2004; 61: 669–80
- Adli M, Berghofer A, Linden M, et al. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: Results of a 2-year observational algorithm study. J Clin Psychiatry 2002; 63: 782–90
- Mellman TA, Miller AL, Weissman EM, et al. Evidence-based pharmacological treatment for people with severe mental illness: A focus on guidelines and algorithms. Psychiatric Services 2001; 52: 619–25
- American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993;150(Suppl 4):S1–26.
- Jobson KO, Potter WZ. International psychopharmacology algorithm project report. Psychopharmacol Bull 1995; 31: 457–9
- Crismon ML, Trivedi M, Pigott TA, et al. The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999; 60: 142–56
- Frances A, Kahn D, Carpenter D, Frances C, Docherty J. A new method of developing expert consensus practice guidelines. Am J Man Care 1998; 4: 1023–9
- Kahn DA, Docherty JP, Carpenter D, Frances A. Consensus methods in practice guideline development: A review and description of a new method. Psychopharmacol Bull 1997; 33: 631–9
- Keller MB. Diagnostic issues and clinical course of unipolar illness. Rev Psychiatry 1988; 7: 188–212
- NIMH/NIH Consensus development panel. Mood disorders: Pharmacologic prevention of recurrences. (NIMH/NIH consensus development conference statement) Am J Psychiatry 1985;142:469–76.
- Mischoulon D, Nirenberg AA, Kizilbash L, Rosenbaum JF, Fava M. Strategies for managing depression refractory to selective serotonin inhibitor treatment: a survey on clinicians. Can J Psychiatry 2000; 45: 476–81
- Fredman SJ, Fava M, Kienke AS, White CN, Nirenberg AA, Rosenbaum JF. Partial response, nonresponse, and relapse with selective serotonin inhibitor treatment in major depression; A survey of current “next-step” practices. J Clin Psychiatry 2000; 61: 403–8
- Fava M, Rosenbaum JF, Cohen L, Reiter S, McCarthy M, et al. High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine. J Affect Disord 1992; 25: 229–34
- Canadian Psychiatric Association. Clinical guidelines for the treatment of depressive disorders. IV. Medication and other Biological treatments. Can J Psychiatry 2001;46(Suppl 1): 385–585.
- Perry PJ. Pharmacotherapy for major depression with melancholic feature: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disorder 1996; 39: 1–6
- Hirschfeld RMA, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastapar M, et al. Partial response and nonresponse to antidepressant therapy: Current approaches and treatment options. J Clin Psychiatry 2002; 63: 826–37
- Fava M. New approaches to the treatment of refractory depression. J Clin Psychiatry 2000; 61(Suppl 1)26–32
- Joffe RT, Levitt AJ. Relationship between antidepressant partial and nonresponse and subsequent response to antidepressant augmentation. J Affect Disorder 1999; 52: 257–9
- Trivedi MH, DeBattista C, Fawcett J, et al. Developing treatment algorithms for unipolar depression in cyberspace: International Psychopharmacology Algorithm Project(IPAP). Psychopharmacol Bull 1998; 34(3)355–9